Literature DB >> 8274412

Catecholestrogens are MCF-7 cell estrogen receptor agonists.

N Schütze1, G Vollmer, I Tiemann, M Geiger, R Knuppen.   

Abstract

Catecholestrogens are important metabolites of estradiol and estrone in the human. Considerable interest has focused on the catecholestrogens 2-hydroxy- and 4-hydroxyestradiol since they bind to the estrogen receptor with an affinity in the range of estradiol. Using the MCF-7 cell line, we analysed the capacity of purified catecholestrogens to transform the estrogen receptor into its high affinity nuclear binding form and to affect receptor-dependent processes such as proliferation and expression of the progesterone receptor (PR). Incubations with 2-hydroxy- and 4-hydroxyestradiol at 10(-8) M for 1 h resulted in tight nuclear binding of the estrogen receptor. During treatment of the cells with catecholestrogens we obtained a marked increase in proliferation rate of 36 and 76% for 2-hydroxy- and 4-hydroxyestradiol, respectively, relative to the inductive effect of estradiol (100%). The PR level, was slightly increased by treatment with 2-hydroxyestradiol (10%), whereas treatment with 4-hydroxyestradiol increased the PR level at 28%, compared to estradiol (100%). From these results we conclude that the 2- and 4-hydroxylated derivatives of estradiol are active hormones and are able to initiate estrogen receptor mediated processes in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274412     DOI: 10.1016/0960-0760(93)90319-r

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  12 in total

1.  2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1.

Authors:  Qian-fen Gong; E-hu Liu; Rong Xin; Xiuning Huang; Ning Gao
Journal:  Mol Cell Biochem       Date:  2011-02-23       Impact factor: 3.396

2.  Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.

Authors:  Karma C Fussell; Ronald G Udasin; Peter J S Smith; Michael A Gallo; Jeffrey D Laskin
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

3.  Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation.

Authors:  Kuan-Wei Peng; Minsun Chang; Yue-Ting Wang; Zhican Wang; Zhihui Qin; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2010-08-16       Impact factor: 3.739

4.  Fat/fiber intakes and sex hormones in healthy premenopausal women in USA.

Authors:  Mylène Aubertin-Leheudre; Sherwood Gorbach; Margo Woods; Johanna T Dwyer; Barry Goldin; Herman Adlercreutz
Journal:  J Steroid Biochem Mol Biol       Date:  2008-08-09       Impact factor: 4.292

5.  Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.

Authors:  A Heather Eliassen; Stacey A Missmer; Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

6.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

7.  Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

Authors:  James D Yager
Journal:  Drug Discov Today Dis Mech       Date:  2012-06-01

8.  CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.

Authors:  V G Martinez; R O'Connor; Y Liang; M Clynes
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

9.  The E-screen assay: a comparison of different MCF7 cell stocks.

Authors:  M Villalobos; N Olea; J A Brotons; M F Olea-Serrano; J M Ruiz de Almodovar; V Pedraza
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

10.  Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments.

Authors:  Lakshmanaswamy Rajkumar; Raphael C Guzman; Jason Yang; Gudmundur Thordarson; Frank Talamantes; Satyabrata Nandi
Journal:  Breast Cancer Res       Date:  2003-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.